Intensive therapy and autologous stem cell transplantation for Hodgkin's disease in first relapse after combination chemotherapy

Leukemia and Lymphoma

Volumn 21, Issue 3-4, 1996, Pages 245-253

  Reece, D E ^a,b   Phillips, G L ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Autologous hematopoietic stem cell transplantation (ASCT); First relapse; Hodgkin's disease (HD); Intensive therapy

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ARTICLE; AUTOTRANSPLANTATION; CLINICAL TRIAL; FOLLOW UP; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; STEM CELL TRANSPLANTATION; SURVIVAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0029935365     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199209067606     Document Type: Article

References (13)

1. Bierman, P. J., Bagin, R. G., Jagannath S., et al. (1993) High-dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients. Ann. Oncol, 4, 767-773.
2. Reece, D. E., Barnett, M. J., Connors, J. M., et al. (1991) Intensive chemotherapy with cyclophosphamide, carmustine and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J. Clin. Oncol., 9, 1871-187.
3. Chopra, R., McMillan A. K., Linch, D. C., et al. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease: A single-center eight-year study of 155 patients. Blood, 81, 1137-1145.
4. Horning, S. J., Chao, N. J., Negrin, R.S., et al. (1991) The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: Preliminary data. Ann. Oncol., 2, 47-50.
5. Gianni, A. M., Siena, S., Bregni, M. et al. (1991) Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease. Ann. Oncol., 2, 645-653.
6. Yahalom, J., Gulati, S. C., Toia, M. et al. (1993) Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. J. Clin. Oncol., 11, 1062-1070.
7. Nademanee, A., O'Donnell, M. R., Snyder, D. S., et al. (1995) High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors. Blood., 85, 1381-1390.
8. Reece, D. E., Connors, J. M., Spinelli, J. J., et al. (1994) Intensive therapy with cyclophosphamide, carmustine, etoposide, cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood, 83, 1193-1199.
9. Desch, C. E., Lasala, M. R., Smith, T. J. et al. (1992) The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse. J. Clin. Oncol., 10, 200-209.
10. Canellos, G. P., Anderson, J. R., Propert, K. J. et al. (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N. Engl. J. Med., 321, 1478-1484.
11. Carella, A. M., Carlier, B., Congiu, A. et al. (1991) Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol. Bone Marrow Transplant, 8, 99-103.
12. Fleury, J., Legros, M., Colombat, P. et al. (1993) High dose chemotherapy (HD-CT) followed by autologous stem cell transplanation (ASCT) for poor prognosis stage IV Hodgkin's disease (HD) in first complete (CR1) or good partial response. Centre Jean Perrin, Institute Pooli-Calmettes, Marseille, France. Fifth International Conference on Malignant Lymphoma, Lugano, Italy. Abstract.
13. Moreau, P., Milpied, N., Mechinaud-Lacroix, F. et al. (1993) Early intensive therapy with autotransplantation for high-risk Hodgkin's disease. Leuk. Lymphoma., 12, 51-58.